Sitagliptin phosphate 100 MG Oral Tablet — RxCUI 2709603
RxNorm drug concept · Semantic clinical drug
RxCUI 2709603
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2709603
Official nameSitagliptin phosphate 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped36
Reported Medicaid activity (SDUD)677,787 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sitagliptin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sitagliptin helps your body manage blood sugar more effectively by keeping certain gut hormones active longer after you eat. Those hormones tell your pancreas to release more insul...
- What exactly does sitagliptin do — and will it cure my diabetes?
- On its own, sitagliptin is very unlikely to cause low blood sugar — that's actually one of its advantages. The reason is that it only kicks in when your blood sugar is already elev...
- Can sitagliptin make my blood sugar go too low?
🕸️ Concept Web — How Sitagliptin phosphate 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sitagliptin phosphate 100 MG Oral Tablet
RxCUI 2709603 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Sitagliptin
593411IN -
Sitagliptin phosphate
621590PIN
-
Sitagliptin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Januvia
638596BN
-
Januvia
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sitagliptin Oral Tablet
665032SCDF -
Sitagliptin phosphate Oral Tablet
2709602SCDFP -
Sitagliptin Oral Product
1159662SCDG -
Sitagliptin Pill
1159663SCDG -
Sitagliptin phosphate Oral Product
2709600SCDGP -
Sitagliptin phosphate Pill
2709601SCDGP -
Sitagliptin Oral Tablet [Januvia]
665035SBDF -
Sitagliptin phosphate Oral Tablet [Januvia]
2709605SBDFP - +5 more in this family
-
Sitagliptin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sitagliptin phosphate 100 MG
2709466SCDC -
Sitagliptin phosphate 100 MG Oral Tablet [Januvia]
665036SBD -
Sitagliptin phosphate 100 MG [Januvia]
2709604SBDC
-
Sitagliptin phosphate 100 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sitagliptin phosphate 100 MG
SCDC · 2709466 -
Sitagliptin Oral Tablet
SCDF · 665032 -
Sitagliptin phosphate Oral Tablet
SCDFP · 2709602 -
Sitagliptin Oral Product
SCDG · 1159662 -
Sitagliptin Pill
SCDG · 1159663 -
Sitagliptin phosphate Oral Product
SCDGP · 2709600 -
Sitagliptin phosphate Pill
SCDGP · 2709601
Brand-Name Concepts
-
Sitagliptin phosphate 100 MG Oral Tablet [Januvia]
SBD · 665036 -
Sitagliptin phosphate 100 MG [Januvia]
SBDC · 2709604 -
Sitagliptin Oral Tablet [Januvia]
SBDF · 665035 -
Sitagliptin phosphate Oral Tablet [Januvia]
SBDFP · 2709605 -
Januvia Oral Product
SBDG · 1167814 -
Januvia Pill
SBDG · 1167815 -
Januvia
BN · 638596
📦 FDA Products & Package NDCs
14 products · 36 package NDCs
36 package NDCs map to RxCUI 2709603 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00006-0112-28 | 100 BLISTER PACK in 1 CARTON (0006-0112-28) / 1 TABLET, FIL... | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0112-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0112-31) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0112-54 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-0112-54) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0221-28 | 100 BLISTER PACK in 1 CARTON (0006-0221-28) / 1 TABLET, FIL... | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0221-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0221-54 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-0221-54) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-02 | 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-02) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-14 | 2 BLISTER PACK in 1 CARTON (0006-0277-14) / 7 TABLET, FILM... | JANUVIA | Merck Sharp & Dohme LLC | 2012-10-12 |
| 00006-0277-28 | 100 BLISTER PACK in 1 CARTON (0006-0277-28) / 1 TABLET, FIL... | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0277-31) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-33 | 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-33) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-54 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-0277-54) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00006-0277-82 | 1000 TABLET, FILM COATED in 1 BOTTLE (0006-0277-82) | JANUVIA | Merck Sharp & Dohme LLC | 2006-10-16 |
| 00480-2607-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2607-56) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2607-98 | 90 TABLET, FILM COATED in 1 BOTTLE (0480-2607-98) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2608-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2608-56) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2608-98 | 90 TABLET, FILM COATED in 1 BOTTLE (0480-2608-98) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2609-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (0480-2609-10) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2609-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2609-56) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00480-2609-98 | 90 TABLET, FILM COATED in 1 BOTTLE (0480-2609-98) | Sitagliptin | Teva Pharmaceuticals, Inc. | 2026-05-28 |
| 00781-5766-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0781-5766-31) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5766-92 | 90 TABLET, FILM COATED in 1 BOTTLE (0781-5766-92) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5768-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0781-5768-31) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5768-92 | 90 TABLET, FILM COATED in 1 BOTTLE (0781-5768-92) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5770-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (0781-5770-10) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5770-31 | 30 TABLET, FILM COATED in 1 BOTTLE (0781-5770-31) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 00781-5770-92 | 90 TABLET, FILM COATED in 1 BOTTLE (0781-5770-92) | Sitagliptin Phosphate | Sandoz Inc | 2026-01-14 |
| 50090-1036-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-1036-0) | JANUVIA | A-S Medication Solutions | 2014-11-28 |
| 50090-1036-02 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-1036-2) | JANUVIA | A-S Medication Solutions | 2018-06-12 |
| 55154-5042-08 | 1350 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-5042-8) | JANUVIA | Cardinal Health 107, LLC | 2006-10-16 |
| 60505-3643-03 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3643-3) | Sitagliptin | Apotex Corp. | 2026-05-28 |
| 60505-3643-09 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3643-9) | Sitagliptin | Apotex Corp. | 2026-05-28 |
| 60505-3644-03 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-3) | Sitagliptin | Apotex Corp. | 2026-05-28 |
| 60505-3644-09 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-9) | Sitagliptin | Apotex Corp. | 2026-05-28 |
| 60505-3645-03 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-3) | Sitagliptin | Apotex Corp. | 2026-05-28 |
| 60505-3645-09 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-9) | Sitagliptin | Apotex Corp. | 2026-05-28 |
Observed labelers:
Merck Sharp & Dohme LLC (13) ·
Sandoz Inc (7) ·
Teva Pharmaceuticals, Inc. (7) ·
Apotex Corp. (6) ·
A-S Medication Solutions (2) ·
Cardinal Health 107, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.